Ovarian cancer is the second most common gynecological cancer in the world. Often diagnosed at an advanced stage, ovarian cancer has the highest mortality rate among cancers in the female reproductive system. Fortunately, progress in screening and early detection, along with breakthrough therapies, offers promise for treating this disease. Clinical trial enrollment in ovarian cancer studies is challenging since ovarian cancer often presents with gastrointestinal (GI)-related symptoms, and patients need to be referred to gynecologic oncology specialists by their local GI or family medicine doctor. Partnering with the right sites and cooperative groups to navigate the competitive landscape and accelerate enrollment is critical to successfully managing ovarian trials.
Read our fact sheet to learn more about our expertise in ovarian cancer and how it can help advance your clinical research program.
